Published in J Bone Miner Res on June 01, 2013
Role of T-cell reconstitution in HIV-1 antiretroviral therapy-induced bone loss. Nat Commun (2015) 1.63
Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection. PLoS Pathog (2014) 1.03
Does HIV infection increase the risk of perioperative complications after THA? A nationwide database study. Clin Orthop Relat Res (2015) 0.98
Increased Fracture Incidence in Middle-Aged HIV-Infected and HIV-Uninfected Women: Updated Results From the Women's Interagency HIV Study. J Acquir Immune Defic Syndr (2015) 0.94
The impact of common co-morbidities (as measured using the Charlson index) on hip fracture risk in elderly men: a population-based cohort study. Osteoporos Int (2014) 0.92
Lower peak bone mass and abnormal trabecular and cortical microarchitecture in young men infected with HIV early in life. AIDS (2014) 0.90
Bone health in children and adolescents with perinatal HIV infection. J Int AIDS Soc (2013) 0.87
HIV and Bone Disease: A Perspective of the Role of microRNAs in Bone Biology upon HIV Infection. J Osteoporos (2013) 0.83
Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study. Osteoporos Int (2015) 0.82
Increased fracture risk with HIV infection--a growing concern. Nat Rev Endocrinol (2013) 0.79
The protease inhibitors and HIV-associated bone loss. Curr Opin HIV AIDS (2016) 0.78
Increased bone resorption during tenofovir plus lopinavir/ritonavir therapy in Chinese individuals with HIV. Osteoporos Int (2014) 0.78
HIV: an underrecognized secondary cause of osteoporosis? J Bone Miner Res (2013) 0.78
HIV infection and osteoporosis. Bonekey Rep (2015) 0.77
Comparative risk of fracture in men and women with HIV. J Clin Endocrinol Metab (2013) 0.77
Bone Loss in HIV Infection. Curr Treat Options Infect Dis (2017) 0.75
Clinically Indicated Corticosteroids Do Not Affect Bone Turnover During Immune Restoration of Severely Lymphopenic HIV-Infected Patients. AIDS Res Hum Retroviruses (2015) 0.75
Factors associated with fractures in HIV-infected persons: which factors matter? Osteoporos Int (2016) 0.75
Bone health in HIV and hepatitis B or C infections. Ther Adv Musculoskelet Dis (2016) 0.75
Perspectives on menopause and women with HIV. Int J Womens Health (2016) 0.75
Osteoporosis knowledge, self-efficacy, and health beliefs among Chinese individuals with HIV. Arch Osteoporos (2014) 0.75
An Increased Rate of Fracture Occurs a Decade Earlier in HIV+ Compared to HIV- men in the Multicenter AIDS Cohort Study (MACS). AIDS (2017) 0.75
Emphysema is associated with thoracic vertebral bone attenuation on chest CT scan in HIV-infected individuals. PLoS One (2017) 0.75
Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med (2014) 6.56
Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr (2002) 4.39
Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Med (2005) 2.84
The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med (2006) 2.74
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection. N Engl J Med (2003) 2.64
Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis. J Acquir Immune Defic Syndr (2009) 2.14
Caffeine and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Clin Nutr (2005) 2.07
[Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National Plan for AIDS for the initial antiretroviral therapy in adult human immunodeficiency virus (HIV) infected patients in 2012]. Enferm Infecc Microbiol Clin (2012) 2.02
[Community bacteremia ambulatory treated or identified after discharge from the emergency department]. Med Clin (Barc) (2007) 2.01
The tissue diagnostic instrument. Rev Sci Instrum (2009) 1.82
Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors. Diabetes Care (2005) 1.80
Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001. J Bone Miner Res (2009) 1.76
[Cardiovascular disease in HIV-infected patients on highly active antiretroviral therapy]. Med Clin (Barc) (2004) 1.68
Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study. PLoS Med (2006) 1.68
Timing of acute myocardial infarction in patients undergoing total hip or knee replacement: a nationwide cohort study. Arch Intern Med (2012) 1.66
Risk factors for prediction of inadequate response to antiresorptives. J Bone Miner Res (2012) 1.61
Changes in mortality patterns following total hip or knee arthroplasty over the past two decades: a nationwide cohort study. Arthritis Rheumatol (2014) 1.61
The association between fracture and obesity is site-dependent: a population-based study in postmenopausal women. J Bone Miner Res (2012) 1.58
A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res (2014) 1.56
Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study. J Bone Miner Res (2014) 1.52
Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial. Arthritis Rheum (2008) 1.51
Impact of syphilis infection on HIV viral load and CD4 cell counts in HIV-infected patients. J Acquir Immune Defic Syndr (2007) 1.51
Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int (2011) 1.50
[Usefulness of FRAX tool for the management of osteoporosis in the Spanish female population]. Med Clin (Barc) (2011) 1.49
Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens (2006) 1.48
Alcohol and risk of atrial fibrillation or flutter: a cohort study. Arch Intern Med (2004) 1.48
Fracture risk in users of oral anticoagulants: a nationwide case-control study. Int J Cardiol (2006) 1.46
[Fragility non-spinal fractures in a cohort of 5,201 women aged 65 years and older during a 3-year follow-up]. Med Clin (Barc) (2006) 1.46
Microindentation for in vivo measurement of bone tissue material properties in atypical femoral fracture patients and controls. J Bone Miner Res (2013) 1.45
[Predictive factors for pneumonia in adults infected with the new pandemic A (H1H1) influenza virus]. Rev Esp Quimioter (2011) 1.42
[Denosumab--a new efficient osteoporosis therapy]. Ugeskr Laeger (2011) 1.39
[Assessment and management of kidney disease in the HIV-1-infected patient. A practical review]. Enferm Infecc Microbiol Clin (2010) 1.39
Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosis. J Infect (2011) 1.39
Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study. AIDS (2010) 1.39
Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP). Inform Prim Care (2011) 1.32
Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods. Clin Endocrinol (Oxf) (2008) 1.31
Trend in mortality after stroke with atrial fibrillation. Am J Med (2007) 1.26
Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab (2011) 1.24
Subclinical carotid atherosclerosis in HIV-infected patients: role of combination antiretroviral therapy. Stroke (2006) 1.23
The risk of fracture in patients with multiple sclerosis: the UK general practice research database. J Bone Miner Res (2011) 1.22
Epidemiological characteristics and predictors of late presentation of HIV infection in Barcelona (Spain) during the period 2001-2009. AIDS Res Ther (2011) 1.21
Hypertension in HIV-infected patients: prevalence and related factors. Am J Hypertens (2005) 1.20
Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch Intern Med (2004) 1.18
Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk. J Bone Miner Res (2003) 1.17
Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ (2002) 1.17
Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study. BMC Infect Dis (2013) 1.16
A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression. J Acquir Immune Defic Syndr (2009) 1.16
[Analysis of costs and cost-effectiveness of preferred GESIDA/National AIDS Plan regimens for initial antiretroviral therapy in human immunodeficiency virus infected adult patients in 2013]. Enferm Infecc Microbiol Clin (2013) 1.11
Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: a retrospective cohort study. PLoS One (2012) 1.10
[SIDIAP database: electronic clinical records in primary care as a source of information for epidemiologic research]. Med Clin (Barc) (2012) 1.10
n-3 Fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Clin Nutr (2005) 1.09
The association between fracture site and obesity in men: a population-based cohort study. J Bone Miner Res (2013) 1.08
Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Bone (2007) 1.07
Two new single-nucleotide polymorphisms in the COL1A1 upstream regulatory region and their relationship to bone mineral density. J Bone Miner Res (2002) 1.07
Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study. J Bone Miner Res (2005) 1.06
[Medical therapy of osteoporosis in patients with mildly to moderate decreased renal function]. Ugeskr Laeger (2012) 1.06
Intake of vitamin D and risk of breast cancer--a meta-analysis. J Steroid Biochem Mol Biol (2008) 1.06
Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies. Curr Drug Saf (2013) 1.05
Evaluation of calcaneal quantitative ultrasound in a primary care setting as a screening tool for osteoporosis in postmenopausal women. J Clin Densitom (2003) 1.05
Trends in incidence and mortality in the hospital diagnosis of atrial fibrillation or flutter in Denmark, 1980-1999. Int J Cardiol (2005) 1.04
Incidence of fractures in patients with multiple sclerosis: the Danish National Health Registers. Mult Scler (2011) 1.03
Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide. J Bone Miner Res (2005) 1.03
Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women. J Bone Miner Res (2004) 1.03
Moisturizing body milk as a reservoir of Burkholderia cepacia: outbreak of nosocomial infection in a multidisciplinary intensive care unit. Crit Care (2008) 1.01
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev (2009) 1.01
Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study. J Acquir Immune Defic Syndr (2009) 0.99
HIV infection and its association with an excess risk of clinical fractures: a nationwide case-control study. J Acquir Immune Defic Syndr (2014) 0.99
Hip fracture risk in statin users--a population-based Danish case-control study. Osteoporos Int (2004) 0.99
Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J Clin Endocrinol Metab (2014) 0.98
Applications of a New Handheld Reference Point Indentation Instrument Measuring Bone Material Strength. J Med Device (2013) 0.98
Use of metformin and survival of diabetic women with breast cancer. Curr Drug Saf (2013) 0.98
Chronic kidney disease prevalence and risk factors among HIV-infected patients. J Acquir Immune Defic Syndr (2008) 0.98
Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study. Breast Cancer Res Treat (2010) 0.98
Decreased fracture risk in users of organic nitrates: a nationwide case-control study. J Bone Miner Res (2006) 0.98
Determinants of plasma PTH and their implication for defining a reference interval. Clin Endocrinol (Oxf) (2011) 0.97
Fracture risk in perimenopausal women treated with beta-blockers. Calcif Tissue Int (2004) 0.96
Ataxic form of central pontine myelinolysis. Lancet Neurol (2002) 0.96
Clinical utility of maraviroc. Clin Drug Investig (2011) 0.96
Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trial. Int J Endocrinol (2009) 0.96
Validity for use in research on vascular diseases of the SIDIAP (Information System for the Development of Research in Primary Care): the EMMA study. Rev Esp Cardiol (Engl Ed) (2011) 0.94
Treatment with raloxifene for 2 years increases vertebral bone mineral density as measured by volumetric quantitative computed tomography. Bone (2004) 0.94
Familial hypocalciuric hypercalcaemia: a review. Curr Opin Endocrinol Diabetes Obes (2011) 0.93
Trends in risk of stroke in patients with a hospital diagnosis of nonvalvular atrial fibrillation: National Cohort Study in Denmark, 1980-2002. Neuroepidemiology (2006) 0.91
Effect of IL-1beta, PGE(2), and TGF-beta1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts. J Cell Biochem (2010) 0.91
Regulation of CYP19 gene expression in primary human osteoblasts: effects of vitamin D and other treatments. Eur J Endocrinol (2003) 0.90
Renal stones and calcifications in patients with primary hyperparathyroidism: associations with biochemical variables. Eur J Endocrinol (2012) 0.90
Bone health in a prospective cohort of postmenopausal women receiving aromatase inhibitors for early breast cancer. Breast (2011) 0.90
Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism. Eur J Endocrinol (2008) 0.90
Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs? Pharmacoepidemiol Drug Saf (2012) 0.90
Relationship between mortality and BMI after fracture: a population-based study of men and women aged ≥40 years. J Bone Miner Res (2014) 0.90
The ECOS-16 questionnaire for the evaluation of health related quality of life in post-menopausal women with osteoporosis. Health Qual Life Outcomes (2004) 0.89